home · filing · 0001493152-23-044529
8-K
filed December 12, 2023, 6:59 PM ET
ticker SIGY
CIK 0001642159
leadership
confidence high
sentiment neutral
materiality 0.50
Sigyn Therapeutics removes CFO Jeremy Ferrell, appoints Jerry DeCiccio as replacement
Sigyn Therapeutics, Inc.
Jeremy Ferrell removed as CFO effective immediately; no disagreements cited.
Jerry DeCiccio appointed CFO effective immediately; he is a CPA with 40+ years experience.
DeCiccio most recently served as a consultant; holds BA from Loma Linda and MBA from USC.
Executive movements
Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements .
Effective 2023-12-12
Successor Jerry DeCiccio
Filed December 12, 2023, 6:59 PM ET
the Company removed Jeremy Ferrell from his position as CFO of the Company, effective immediately.
Effective 2023-12-12
Filed December 12, 2023, 6:59 PM ET
The Company has appointed Jerry DeCiccio to serve as the Chief Financial Officer of the Company, effective immediately.
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 1.0
Jeremy Ferrell was removed as Chief Financial Officer at Sigyn Therapeutics, Inc..
Action removed
Role Chief Financial Officer
Exact text from the filing
the Company removed Jeremy Ferrell from his position as CFO of the Company, effective immediately.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 1.0
Jerry DeCiccio was appointed as Chief Financial Officer at Sigyn Therapeutics, Inc..
Action appointed
Role Chief Financial Officer
Exact text from the filing
The Company has appointed Jerry DeCiccio to serve as the Chief Financial Officer of the Company, effective immediately.
View on SEC.gov
Source: SEC EDGAR
accession 0001493152-23-044529
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.